Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Active System; Avenue8

K-Number: K241395 · 2024-12-18

Decision Date2024-12-18
Product CodeILX
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

Active System; Avenue8 is the device name listed in this FDA 510(k) record. The listed applicant is Caerus Corporation. It received FDA 510(k) clearance on 2024-12-18 under 510(k) number K241395. The device is classified under product code ILX. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Active System; Avenue8?

Active System; Avenue8 is a medical device that received FDA 510(k) clearance on 2024-12-18. The listed applicant is Caerus Corporation. The 510(k) number is K241395.

When did Active System; Avenue8 receive FDA 510(k) clearance?

Active System; Avenue8 received FDA 510(k) clearance on 2024-12-18, under 510(k) number K241395.

Who is the listed applicant for Active System; Avenue8?

The FDA 510(k) record lists Caerus Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Active System; Avenue8?

The FDA product code for Active System; Avenue8 is ILX.

Related Devices (Code: ILX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.